Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

Targeting cellular senescence may improve skin aging and disorders.

Abrocitinib may effectively treat stubborn alopecia universalis.

Vitamin D is important for skin health, but more research is needed to understand its full effects and treatment potential.

Rosacea is a common skin condition mainly causing facial redness.

Chronic skin diseases and metabolic syndrome are linked by shared inflammation pathways.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

cGVHD often severely affects the skin, causing rapid aging and other issues.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

COVID-19 can worsen autoimmune skin diseases and increase their occurrence.

Healthcare access for alopecia areata in the USA is unequal among ethnic groups.

ICD codes for skin conditions vary in accuracy, needing better validation for some common conditions.

Microneedles offer a promising, less invasive way to treat and monitor psoriasis.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Light/laser therapy can effectively increase hair density in some types of alopecia, especially androgenic alopecia and alopecia areata.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

The combined treatment for hair loss is effective, easy to use, and has mild side effects.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

More high-quality research is needed to recommend flavonoids and saponins for clinical use.

Sildenafil may help with some skin conditions and hair growth, but more research is needed.

Alopecia Areata causes hair loss and needs treatments that address both physical and emotional health.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Extracellular vesicles show potential in dermatology, but more research is needed for validation.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.